At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation ...

A Woburn biotechnology company is now facing a significantly larger wave of layoffs than initially disclosed — with state filings suggesting between 161 and 224 Massachusetts employees are on the ...

We'll know more about the company's medium-term prospects by the end of the year.

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.

In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The agreement came four months too late.

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

EVERETT — Sana Biotechnology has canceled plans to build a major biotech manufacturing factory in Bothell that was supposed to employ hundreds of workers within a few years. The publicly traded ...